Načítá se...
Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland
INTRODUCTION: Co-testing (cytology plus human papillomavirus DNA testing) as part of cervical cancer surveillance in Ireland increases one-time testing costs. Of interest to policy makers was the long-term impact of these costs accompanied by decreases in intensity of recalls for women with no detec...
Uloženo v:
| Vydáno v: | Expert Rev Pharmacoecon Outcomes Res |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5902188/ https://ncbi.nlm.nih.gov/pubmed/26377838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737167.2015.1057126 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|